After the Infection Is Gone: MassCPR experts discuss the knowns and unknowns of long COVID.
Original article from Harvard Medical School News by Ekaterina Pesheva. June 9, 2022
As the vast majority of the world’s population continues to encounter SARS-CoV-2 virus and become infected, one question looms ever larger: What will be the long-term physiological repercussions of having had COVID?
Experts from the Harvard Medical School–led Massachusetts Consortium on Pathogen Readiness discuss the emerging science, latest knowledge, and critical unknowns of the novel syndrome known as long COVID.
- Nahid Bhadelia, founding director, Boston University Center for Emerging Infectious Diseases Policy and Research; associate professor of infectious diseases, Boston University School of Medicine; visiting fellow, the White House Office of Science & Technology Policy; long COVID research group co-lead for MassCPR
- Bruce Levy, HMS Parker B. Francis Professor of Medicine and division chief of pulmonary and critical care medicine at Brigham and Women’s Hospital; long COVID research group co-lead for MassCPR
- Linda Sprague Martinez, associate professor, Boston University School of Social Work; co-director, Community Engagement Program, BU Clinical & Translational Science Institute; long COVID research group health disparities lead for MassCPR
- Jake Lemieux, instructor in medicine, Harvard Medical School, infectious disease specialist at Mass General; viral variants program co-lead for MassCPR